AWA
ITCI

Arete Wealth Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Arete Wealth Advisors’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-12,117
Closed -$1.6M – 818
2025
Q1 		$1.6M Sell
12,117
-12,100
-50% -$1.51M 0.12% 171
2024
Q4 		$2.02M Sell
24,217
-850
-3% -$69.8K 0.15% 139
2024
Q3 		$1.83M Buy
25,067
+4,517
+22% +$339K 0.16% 134
2024
Q2 		$1.41M Sell
20,550
-5,065
-20% -$351K 0.12% 176
2024
Q1 		$1.77M Sell
25,615
-43
-0.2% -$2.96K 0.16% 144
2023
Q4 		$1.84M Buy
25,658
+81
+0.3% +$4.66K 0.14% 153
2023
Q3 		$1.33M Buy
+25,577
New +$1.49M 0.23% 97

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Arete Wealth Advisors's ITCI Position: Q2 2025 in Review

Arete Wealth Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 12,117 shares — an estimated $1.6M sold.

Arete Wealth Advisors first reported a position in ITCI in Q3 2023 and held it in 7 quarters. The position peaked at $2.02M in Q4 2024. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Arete Wealth Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Arete Wealth Advisors sold 12,117 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $1.6M.
  • Arete Wealth Advisors first reported a position in Intra-Cellular Therapies Inc. in Q3 2023 and held it in 7 quarters.
  • Arete Wealth Advisors's Intra-Cellular Therapies Inc. position peaked at $2.02M in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Arete Wealth Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.